Ipamorelin: Mechanistic Overview
internal_protocol · preclinical · status: needs_provider_review
Metadata
Author: Axiom Knowledge Base
Citation: Internal reference summary compiled for the Axiom knowledge base (2026).
Embedding: pending
File: signed link
Summary (generated — provider review required)
Ipamorelin is a selective growth-hormone secretagogue (ghrelin-receptor agonist) that stimulates GH release with relatively little effect on cortisol/prolactin. Mechanism: pulsatile GH release. Relevance: recovery and sleep/body-composition contexts.
The original source document remains the source of truth. Generated summaries are not authoritative.
Linked assets (4) · phenotypes (0)
evidence_reference, mechanism, safety_reference, dosing_reference
Evidence claims (4) · review items (2)
mechanism · pending
Ipamorelin is a selective growth-hormone secretagogue (ghrelin-receptor agonist) that stimulates GH release with relatively little effect on cortisol/prolactin.
mechanism · pending
Mechanism: pulsatile GH release.
safety · pending
Safety: human evidence limited; regulatory status varies.
dosing · pending
Background for provider review only — not a treatment recommendation or dosing guidance.
Extracted chunks (1)
47 approx tokens across 1 chunks.